Growth Metrics

Vivos (RDGL) Debt to Equity (2011 - 2023)

Vivos recorded quarterly Debt to Equity of $0.01 in Q3 2023, up 100.79% quarter-over-quarter from -$0.87 in Q3 2018.

Vivos' Debt to Equity history runs 9 years deep, the most recent figure standing at $0.01 for Q3 2023.

  • In Q3 2023, Debt to Equity changed N/A year-over-year to $0.01; the TTM figure through Sep 2023 stood at $0.01 (changed N/A YoY), while the FY2016 annual figure was -$0.15, up 50.7% from the prior year.
  • Debt to Equity came in at $0.01 for Q3 2023 at Vivos, up from -$0.87 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.01 in Q3 2023 to a low of $0.01 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Vivos - - -3,105.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 0.01
Sep 30, 2018 -0.87
Jun 30, 2018 -0.49
Mar 31, 2018 -0.01
Sep 30, 2017 -0.11
Jun 30, 2017 -0.03
Mar 31, 2017 -0.03
Dec 31, 2016 -0.15
Sep 30, 2016 -0.02
Jun 30, 2016 -0.07
Mar 31, 2016 -0.07
Dec 31, 2015 -0.30
Sep 30, 2015 -0.31
Jun 30, 2015 -0.01
Mar 31, 2015 -0.43
Dec 31, 2014 -0.22
Sep 30, 2014 -0.05
Jun 30, 2014 -0.22
Mar 31, 2014 -0.05
Dec 31, 2013 -0.04
Sep 30, 2013 -0.16
Jun 30, 2013 -0.16
Dec 31, 2012 0.00
Sep 30, 2012 -0.01
Jun 30, 2012 -0.02
Mar 31, 2012 -0.03
Jun 30, 2011 -0.01